| Lowering apolipoprotein CIII protects against high-fat diet–induced metabolic derangements I Valladolid-Acebes, K Åvall, P Recio-López, N Moruzzi, G Bryzgalova, ... Science advances 7 (11), eabc2931, 2021 | 15 | 2021 |
| Genetic mimicry analysis reveals the specific lipases targeted by the ANGPTL3-ANGPTL8 complex and ANGPTL4 F Landfors, E Chorell, S Kersten Journal of Lipid Research 64 (1), 2023 | 11 | 2023 |
| Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma O Kovrov, F Landfors, V Saar-Kovrov, U Näslund, G Olivecrona Journal of Lipid Research 63 (1), 2022 | 9 | 2022 |
| Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk F Landfors, P Henneman, E Chorell, SK Nilsson, S Kersten European Heart Journal Open 4 (3), oeae035, 2024 | 5 | 2024 |
| CETP inhibition Reduces Cardiovascular Events by Lowering of Cumulative LDL Exposure: Reconciling Evidence from Human Genetics and Clinical Trials F Landfors, JJP Kastelein, E Chorell medRxiv, 2024.12. 02.24318306, 2024 | | 2024 |
| Effects of human plasma components on the activity of lipoprotein lipase: a study of samples from the vipviza trial using isothermal titration calorimetry O Kovrov, F Landfors, V Saar-Kovrov, U Näslund, G Olivecrona Atherosclerosis 315, e24, 2020 | | 2020 |
